Investing in Future Vaccines

Jason and David discuss the inefficiency of government spending on COVID fighting and propose investing in biomanufacturing infrastructure to quickly develop and deploy vaccines in the future. They highlight the cost-effectiveness and potential of modular biomanufacturing facilities in supporting the vaccine supply chain.